BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6698636)

  • 1. Age at first birth and breast atypia.
    Hsieh CC; Walker AM; Trapido EJ; Crosson AW; MacMahon B
    Int J Cancer; 1984 Mar; 33(3):309-12. PubMed ID: 6698636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia.
    Pastides H; Kelsey JL; Holford TR; LiVolsi VA
    Am J Epidemiol; 1985 Mar; 121(3):440-7. PubMed ID: 4014134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
    Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
    J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series.
    Pathak DR; Pike MC; Key CR; Teaf SR; Bartow SA
    Br J Cancer; 1991 Jun; 63(6):1005-9. PubMed ID: 2069834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE; Miller AB
    Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence rates and risk factors of benign breast neoplasms.
    Cole P; Mark Elwood J; Kaplan SD
    Am J Epidemiol; 1978 Aug; 108(2):112-20. PubMed ID: 707472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and fibrocystic breast disease of different histologic classifications.
    Hsieh CC; Crosson AW; Walker AM; Trapido EJ; MacMahon B
    J Natl Cancer Inst; 1984 Feb; 72(2):285-90. PubMed ID: 6582316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
    Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China.
    Li W; Ray RM; Lampe JW; Lin MG; Gao DL; Wu C; Nelson ZC; Fitzgibbons ED; Horner N; Hu YW; Shannon J; Satia JA; Patterson RE; Stalsberg H; Thomas DB
    Int J Cancer; 2005 Jul; 115(6):981-93. PubMed ID: 15723298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000.
    Wu C; Ray RM; Lin MG; Gao DL; Horner NK; Nelson ZC; Lampe JW; Hu YW; Shannon J; Stalsberg H; Li W; Fitzgibbons D; Porter P; Patterson RE; Satia JA; Thomas DB
    Am J Epidemiol; 2004 Nov; 160(10):945-60. PubMed ID: 15522851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of fibrocystic breast disease.
    Simard A; Vobecky J; Vobecky JS; Ghadirian P; Lamothe-Guay M; Falardeau M
    Rev Epidemiol Sante Publique; 1993; 41(1):84-9. PubMed ID: 8465069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for benign breast disease: a 30-year cohort study.
    Hislop TG; Elwood JM
    Can Med Assoc J; 1981 Feb; 124(3):283-91. PubMed ID: 7459788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
    Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical patterns of fibrocystic mastopathy in relation to parity and age].
    Panazzolo A; Amosso B; Fantoni A; Ferreri S; Cavuoto F; Chiappa A
    Minerva Ginecol; 1990 Dec; 42(12):519-23. PubMed ID: 2089294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
    Kampert JB; Whittemore AS; Paffenbarger RS
    Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parity, age at first birth and the risk of carcinoma in situ of the breast.
    Lambe M; Hsieh CC; Tsaih SW; Ekbom A; Trichopoulos D; Adami HO
    Int J Cancer; 1998 Jul; 77(3):330-2. PubMed ID: 9663590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylxanthines and benign breast disease.
    Schairer C; Brinton LA; Hoover RN
    Am J Epidemiol; 1986 Oct; 124(4):603-11. PubMed ID: 3752054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.